Klaus Mann

Coronary Risk Stratification, Discrimination, and Reclassification Improvement Based on Quantification of Subclinical Coronary Atherosclerosis

Raimund Erbel, Stefan Möhlenkamp, Susanne Moebus et al. · Journal of the American College of Cardiology · 2010 · 756 citations

Coronary Risk Stratification, Health Policy, Cardiovascular Disease +9

Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: Rationale and design of the Heinz Nixdorf RECALL Study

Axel Schmermund, Stefan Möhlenkamp, Andreas Stang et al. · American Heart Journal · 2002 · 567 citations

Novel Risk Factors, Epidemiology, Cardiovascular Epidemiology +11

Thyrotropin Receptor Autoantibodies Are Independent Risk Factors for Graves’ Ophthalmopathy and Help to Predict Severity and Outcome of the Disease

Anja Eckstein, Marco Plicht, Hildegard Lax et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 474 citations

Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide

Philipp A. Lang, M. Schenck, Jan P. Nicolay et al. · Nature Medicine · 2007 · 439 citations

Hepatology, Biochemistry, Disease Mechanism +12

Quality of Life, Psychosocial Well-Being, and Sexual Satisfaction in Women with Polycystic Ovary Syndrome

Sigrid Elsenbruch, Susanne Hahn, Daniela Kowalsky et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 433 citations · Full text